SGX strikes new path with equity derivatives suite

Singapore NY_PA_575x375
By Ross Lancaster
13 Aug 2020

Singapore Exchange (SGX) revealed a new suite of Asian equity derivatives this week, as it gave investors a look at what its strategy after winding down its high profile licensing agreement with MSCI will be.

In May, SGX announced that a licensing agreement with MSCI to use indices providing Asian and emerging markets exposure as underlyings for derivatives would end in February 2021. Rival HKEX took up the agreement and last week ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial